Published in FDA Law Weekly, March 22nd, 2007
"What was not anticipated, however, was that the tumors treated with LF would have a substantially reduced vascular content. This intriguing result was one...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of FDA Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.